CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 6 filers reported holding CHINA BIOLOGIC PRODS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $7,682,000 | +9.6% | 67,922 | -3.0% | 2.10% | +20.5% |
Q1 2017 | $7,012,000 | -28.1% | 70,032 | -22.8% | 1.74% | -24.3% |
Q4 2016 | $9,757,000 | -16.4% | 90,748 | -3.2% | 2.30% | -14.7% |
Q3 2016 | $11,674,000 | +16.7% | 93,784 | -0.3% | 2.70% | +10.6% |
Q2 2016 | $10,002,000 | +2.0% | 94,074 | +9.9% | 2.44% | -8.3% |
Q1 2016 | $9,802,000 | -30.1% | 85,623 | -13.0% | 2.66% | -24.3% |
Q4 2015 | $14,028,000 | +31.3% | 98,470 | +5.3% | 3.51% | +23.6% |
Q3 2015 | $10,681,000 | +47.2% | 93,479 | +58.2% | 2.84% | +11.2% |
Q2 2015 | $7,258,000 | +27.1% | 59,101 | -1.2% | 2.56% | +14.3% |
Q1 2015 | $5,710,000 | +280.9% | 59,789 | +168.1% | 2.24% | +263.6% |
Q4 2014 | $1,499,000 | +31.7% | 22,299 | +5.7% | 0.62% | +37.0% |
Q3 2014 | $1,138,000 | +29.2% | 21,093 | +6.4% | 0.45% | +17.8% |
Q2 2014 | $881,000 | +7.4% | 19,819 | -16.0% | 0.38% | +14.4% |
Q1 2014 | $820,000 | +5.1% | 23,600 | -12.7% | 0.33% | -2.6% |
Q4 2013 | $780,000 | +17.5% | 27,040 | +18.9% | 0.34% | +8.6% |
Q3 2013 | $664,000 | – | 22,746 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WARBURG PINCUS LLC | 10,989,200 | $1,049,578,000 | 7.88% |
RUDMAN ERROL M | 110,201 | $10,525,000 | 3.65% |
Ativo Capital Management LLC | 59,789 | $5,710,000 | 2.24% |
OBERWEIS ASSET MANAGEMENT INC/ | 56,200 | $5,368,000 | 1.51% |
Granite Point Capital Management, L.P. | 40,000 | $3,820,000 | 1.40% |
Cormorant Asset Management, LP | 76,500 | $7,307,000 | 1.13% |
Spark Investment Management LLC | 52,800 | $5,031,000 | 0.70% |
Grandeur Peak Global Advisors, LLC | 33,050 | $3,157,000 | 0.67% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 198,454 | $18,954,000 | 0.66% |
Visium Asset Management, LP | 438,008 | $41,834,000 | 0.62% |